Royal Society of Chemistry, MedChemComm, 3(5), p. 333
DOI: 10.1039/c3md00278k
Full text: Unavailable
Through high-throughput screening of 200 000 compounds and subsequent structure–activity relationship (SAR) studies we identified necrosulfonamide (NSA) as a potent small molecule inhibitor for necroptosis, induced by a combination of TNF-a, Smac mimetic, and z-VAD-fmk (T/S/Z).